Non‐pituitary growth hormone enables colon cell senescence evasion

Abstract

AbstractDNA damage‐induced senescence is initially sustained by p53. Senescent cells produce a senescence‐associated secretory phenotype (SASP) that impacts the aging microenvironment, often promoting cell transformation. Employing normal non‐tumorous human colon cells (hNCC) derived from surgical biopsies and three‐dimensional human intestinal organoids, we show that local non‐pituitary growth hormone (npGH) induced in senescent cells is a SASP component acting to suppress p53. npGH autocrine/paracrine suppression of p53 results in senescence evasion and cell‐cycle reentry, as evidenced by increased Ki67 and BrdU incorporation. Post‐senescent cells exhibit activated epithelial‐to‐mesenchymal transition (EMT), and increased cell motility. Nu/J mice harboring GH‐secreting HCT116 xenografts with resultant high GH levels and injected intrasplenic with post‐senescent hNCC developed fourfold more metastases than did mice harboring control xenografts, suggesting that paracrine npGH enables post‐senescent cell transformation. By contrast, senescent cells with suppressed npGH exhibit downregulated Ki67 and decreased soft agar colony formation. Mechanisms underlying these observations include npGH induction by the SASP chemokine CXCL1, which attracts immune effectors to eliminate senescent cells; GH, in turn, suppresses CXCL1, likely by inhibiting phospho‐NFκB, resulting in SASP cytokine downregulation. Consistent with these findings, GH‐receptor knockout mice exhibited increased colon phospho‐NFκB and CXCL1, while GH excess decreased colon CXCL1. The results elucidate mechanisms for local hormonal regulation of microenvironmental changes in DNA‐damaged non‐tumorous epithelial cells and portray a heretofore unappreciated GH action favoring age‐associated epithelial cell transformation.